1.
Long term cost-effectiveness of Oncotype DX test vs current clinical practice from a Dutch cost perspective
2.
Participation of general practitioners in disease management: experiences from the Netherlands
3.
4.
5.
Cost-effectiveness of oncotype DX (R) test vs current clinical practice: a Dutch cost perspective